Clinical trials are under way for a candidate vaccine for Lassa fever at the University of Maryland School of Medicine, sponsored by NIH’s National Institute of Allergy and Infectious Diseases. The LASSARAB vaccine, using an inactivated rabies virus has already been shown to protect animals from lethal doses of Lassa virus. The disease, spread by rodents and person-to-person contact, often results in severe illness and permanent hearing loss. There are currently no specific treatments for Lassa fever.
BSI Warns Of New Captcha Scam Spreading Malware
Cybercriminals are exploiting Captchas, symbols of online security, to trick users into downloading malicious software, warns the Bundesamt für Sicherheit und Informationstechnik (BSI). This new
